Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Vir Biotechnology, Inc. (VIR)

NASDAQ

$10.45

$--

(0.00%)

Pre-Market

Vir Biotechnology, Inc. (VIR) Live Price Chart

Last updated: ⁦2026-09-16 09:04:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Vir Biotechnology, Inc. (VIR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $10.45, with a market capitalisation of $1.82B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.75 to $11.94. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.82B
Open	$10.45
Day's High	$141.01
Day's Low	$4.16
Previous Close	$10.44
Volume	5.00
Average Volume	1.97M
P/E Ratio	--
52-Week High	$11.94
52-Week Low	$4.75
Dividend Yield	--
Earnings Date	--

Vir Biotechnology, Inc. (VIR) Pre-Market Stock Price

Vir Biotechnology, Inc. (VIR) is trading at $10.45 in pre-market trading as of 2026-09-16 08:01:00, up 0.05% ($0.01) from the previous close of $10.44

Pre-market trading shows how investors are pricing VIR before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Vir Biotechnology, Inc. (VIR) 7-Day Stock Price Change

Over the past seven days, Vir Biotechnology, Inc. (VIR) moved from $11.39 to $10.45, representing a decline of 8.26% ($0.94).

The stock traded between $10.23 and $11.65 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.82 million shares, down versus the previous seven-day period, indicating lower trading activity.

VIR 52-Week Price Position

Position in Range: 79.2%

52W Low$4.75

52W High$11.94

VIR is currently trading at $10.45, placing it 79.2% of the way from its 52-week low of $4.75 to its 52-week high of $11.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Vir Biotechnology, Inc. (VIR)?

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Vir Biotechnology, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	367
Exchange	NASDAQ
Company Website	https://www.vir.bio

How to Buy Vir Biotechnology, Inc. (VIR) Stock on MEXC

Eligible investors can buy real shares of Vir Biotechnology, Inc. (VIR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VIR and Place Your Order

Open the RealStocks trading page and search for VIR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Vir Biotechnology, Inc. (VIR) stock price today?

Vir Biotechnology, Inc. (VIR) is currently trading at $ 10.45, up 0.05% ($0.01) from the previous close of $ 10.44. Intraday prices update in real time during regular trading hours.

2.Is VIR stock going up or down today?

As of 2026-09-16 08:01:00, VIR is trading at $ 10.45, up 0.05% ($0.01) from its previous close of $ 10.44. The stock has traded between $ 4.16 and $ 141.01 during today’s regular session. Past price movements do not guarantee future results.

3.What is VIR pre-market price?

As of 2026-09-16 08:01:00, VIR is trading at $ 10.45 in pre-market trading, up 0.05% ($0.01) from the previous close of $ 10.44. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VIR after-hours price?

As of 2026-09-16 08:01:00, VIR is trading at $ 10.45 in after-hours trading, up 0.05% ($0.01) from the regular-session close of $ 10.44. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VIR stock trading now?

VIR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VIR sit relative to its 52-week high and low?

Over the past 52 weeks, VIR has traded between a low of $ 4.75 and a high of $ 11.94. At $ 10.45, the stock is positioned 79.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Vir Biotechnology, Inc. in?

Vir Biotechnology, Inc. (VIR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Vir Biotechnology, Inc.'s market capitalisation and where is it listed?

Vir Biotechnology, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.82B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VIR valued in terms of P/E ratio and EPS?

VIR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.49. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Vir Biotechnology, Inc. pay a dividend?

Vir Biotechnology, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.